These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7729921)

  • 1. A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice.
    Wilson ME; Young BM; Andersen KP; Weinstock JV; Metwali A; Ali KM; Donelson JE
    Infect Immun; 1995 May; 63(5):2062-9. PubMed ID: 7729921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCG expressing LCR1 of Leishmania chagasi induces protective immunity in susceptible mice.
    Streit JA; Recker TJ; Donelson JE; Wilson ME
    Exp Parasitol; 2000 Jan; 94(1):33-41. PubMed ID: 10631078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania chagasi T-cell antigens identified through a double library screen.
    Martins DR; Jeronimo SM; Donelson JE; Wilson ME
    Infect Immun; 2006 Dec; 74(12):6940-8. PubMed ID: 17000724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular immunization with p36(LACK) DNA vaccine induces IFN-gamma production but does not protect BALB/c mice against Leishmania chagasi intravenous challenge.
    Marques-da-Silva EA; Coelho EA; Gomes DC; Vilela MC; Masioli CZ; Tavares CA; Fernandes AP; Afonso LC; Rezende SA
    Parasitol Res; 2005 Dec; 98(1):67-74. PubMed ID: 16261353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and molecular characterization of a gene encoding a protective Leishmania amazonensis Trp-Asp (WD) protein.
    Campbell K; Popov V; Soong L
    Infect Immun; 2004 Apr; 72(4):2194-202. PubMed ID: 15039343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Vaccine Formulations Containing a Modified Version of the Amastigote 2 Antigen and the Non-Virulent
    Almeida APMM; Machado LFM; Doro D; Nascimento FC; Damasceno L; Gazzinelli RT; Fernandes AP; Junqueira C
    Front Immunol; 2018; 9():465. PubMed ID: 29599776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections.
    Zanin FH; Coelho EA; Tavares CA; Marques-da-Silva EA; Silva Costa MM; Rezende SA; Gazzinelli RT; Fernandes AP
    Microbes Infect; 2007 Jul; 9(9):1070-7. PubMed ID: 17644455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis.
    Stäger S; Smith DF; Kaye PM
    J Immunol; 2000 Dec; 165(12):7064-71. PubMed ID: 11120835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis.
    Burns JM; Shreffler WG; Benson DR; Ghalib HW; Badaro R; Reed SG
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):775-9. PubMed ID: 8421715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
    Melby PC; Yang J; Zhao W; Perez LE; Cheng J
    Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete conservation of an immunogenic gene (lcr1) in Leishmania infantum and Leishmania chagasi isolated from Iran, Spain and Brazil.
    Mahmoudzadeh-Niknam H; Abrishami F; Doroudian M; Moradi M; Alimohammadian MH; Parvizi P
    J Vector Borne Dis; 2010 Dec; 47(4):204-10. PubMed ID: 21178212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigens shared by Leishmania species and Trypanosoma cruzi: immunological comparison of the acidic ribosomal P0 proteins.
    Skeiky YA; Benson DR; Elwasila M; Badaro R; Burns JM; Reed SG
    Infect Immun; 1994 May; 62(5):1643-51. PubMed ID: 7513304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides.
    Agallou M; Pantazi E; Tsiftsaki E; Toubanaki DK; Gaitanaki C; Smirlis D; Karagouni E
    Mol Immunol; 2018 Nov; 103():7-20. PubMed ID: 30173073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis.
    Oliveira-da-Silva JA; Machado AS; Ramos FF; Tavares GSV; Lage DP; Mendonça DVC; Pereira IAG; Santos TTO; Martins VT; Carvalho LM; Freitas CS; Ludolf F; Reis TAR; Bandeira RS; Silva AM; Costa LE; Oliveira JS; Duarte MC; Roatt BM; Teixeira AL; Coelho EAF
    Cell Immunol; 2020 Oct; 356():104194. PubMed ID: 32827943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis.
    Ferreira JH; Gentil LG; Dias SS; Fedeli CE; Katz S; Barbiéri CL
    Vaccine; 2008 Jan; 26(5):677-85. PubMed ID: 18160187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania donovani recombinant iron superoxide dismutase B1 protein in the presence of TLR-based adjuvants induces partial protection of BALB/c mice against Leishmania major infection.
    Daifalla NS; Bayih AG; Gedamu L
    Exp Parasitol; 2012 Jul; 131(3):317-24. PubMed ID: 22580023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning, characterization and serological evaluation of K9 and K26: two related hydrophilic antigens of Leishmania chagasi.
    Bhatia A; Daifalla NS; Jen S; Badaro R; Reed SG; Skeiky YA
    Mol Biochem Parasitol; 1999 Aug; 102(2):249-61. PubMed ID: 10498181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis.
    Webb JR; Kaufmann D; Campos-Neto A; Reed SG
    J Immunol; 1996 Dec; 157(11):5034-41. PubMed ID: 8943412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral expression of LACK-mRNA induced by intranasal vaccination with PCI-NEO-LACK defines the protection duration against murine visceral leishmaniasis.
    De Oliveira Gomes DC; Schwedersky RP; Barbosa De-Melo LD; Da Silva Costa Souza BL; De Matos Guedes HL; Lopes UG; Rossi-Bergmann B
    Parasitology; 2012 Oct; 139(12):1562-9. PubMed ID: 23036534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.